Revvity’s EUROIMMUN Unveils New Fully Automated Instrument for Specialty Testing
May 19, 2025
The IDS i20 platform offers fully automated processing of specialty assays in endocrinology, allergy, autoimmune and infectious diseases, Alzheimer’s disease and therapeutic drug monitoring Revvity,